Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Certified by Founder
Lodge
Unlearn.AI
start up
United States
- San Francisco, California
- 19/04/2022
- Series B
- $50,000,000
Accelerating clinical trials with AI.
- Industry Biotechnology
- Website https://www.unlearn.ai/
- LinkedIn https://www.linkedin.com/company/unlearn-ai/
Related People
Charles FisherFounder
United States -
San Francisco Bay Area
Solving the most challenging problems in biology and healthcare using statistical physics and machine learning.
Contacting me:
I am not open to full-time employment opportunities and will not respond to related messages.
LinkedIn
https://www.linkedin.com/in/drckf/
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)